Failed Mesh Implant Complications and Procedures | TVM Settlements

Over 200,000 inpatient surgical procedures are performed in the U.S. itself every year to treat Pelvic organ prolapse (POP) amongst women. Studies show, approximately 13% of those who undergoes the surgery would need a redo of the operation within the next five years while about 30% of them would undergo another surgery for a related prolapse condition in their lifetime. But even though the FDA has classified transvaginal mesh as a high-risk device and  vaginal mesh complications  remain to be one of the most highly reported problems, some surgeons continue to use it to treat POP and SUI. Troubles with vaginal mesh Traditionally, the pelvic organ prolapse surgery was about repairing the damaged connective tissues with sutures that was commonly referred to as vaginal repair. As the procedure had high chances of the prolapse recurring, the introduction of this mesh-like product deemed to be an effective option for treating the condition. From 2003, the Therapeutic Goods Ass

The transvaginal mesh implants have been in the pharmaceutical market for a long time now but there have always been debates and questions about its effectiveness. The FDA, which initially claimed the medical device to be a safe alternative to the existing treatment procedure for pelvic organ prolapse and stress urinary incontinence, has now labeled it as a high-risk device. The severe side effects linked with the mesh implant came to the forefront when thousands of women complained about the problem of mesh erosion. Why need mesh implant? Most women, with growing age, have weakened pelvic floor muscles. To support the region, the mesh implant surgery has seemed to be an easy and efficient option. Unfortunately, there are a number  transvaginal mesh complications  associated with the treatment of SUI and POP; the most common of which is mesh erosion. Understandably, the vaginal mesh breaks off in parts and migrates to different parts of the bowel region creating health compli